Navigation Links
EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
Date:10/7/2007

e will not receive any significant payments under our agreement with Myriad, the risk that the development of our other apoptosis product candidates will not be successful, the risk that our ASAP technology will not yield any successful product candidates, the risk that clinical trials for NP-1 will not be successful, that NP-1 will not receive regulatory approval or achieve significant commercial success, the risk that our other product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later stage clinical trials, the risk that EpiCept will not obtain approval to market any of its product candidates, the risks associated with reliance on additional outside financing to meet its capital requirements, the risks associated with dependence upon key personnel, the risks associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of our product candidates; the cost, delays and uncertainties associated with our scientific research, product development, clinical trials and regulatory approval process; our history of operating losses since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including its reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in EpiCept's filings which are available at http://www.sec.gov or at http://www.epicept.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due
'/>"/>
SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- On Tuesday, July 1, 2014, Eclipse ... 116 th Judicial District Court in ... USA, LLC ("Defendant") for Tortious Interference ... false and misleading actions, fraud, fraud-in-the-inducement, business interference, ... libel, disparagement, defamation, misrepresentation, and violating the false/deceptive ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
(Date:7/23/2014)... SAN DIEGO , July 23, 2014  RT ... has agreed to join its board of directors. ... of Microsoft Corporation, where he works on strategic projects ... Previously, he was Microsoft,s chief research and strategy officer. ... chief executive officer of RainTree, said, "Craig is a ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... VacChina 2011 - - ... - - welcomes world class ... vaccine R&D and manufacturing technologies in China. The ... national regulatory authority of China -- the State Food and Drug ...
... Aug. 18, 2011 Generex Biotechnology Corporation (OTCBB: ... Company,s wholly-owned subsidiary Antigen Express, Inc. ( www.antigenexpress.com ... 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, ... Healthtech Institute,s Sixth Annual ImVacS: The Immunotherapeutics and ...
Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4
(Date:7/23/2014)... (PRWEB) July 23, 2014 Recently, Agebc.com ... . Now, the company is announcing a promotion of ... the promotion will end at the end of this ... in many popular styles, like A-line, mermaid, ball-gown, empire, ... wedding dresses and other special-occasion dresses for women, and ...
(Date:7/23/2014)... Absolute PhysioCare and Sports Rehab, a Burnaby ... custom orthotics and gait scan analysis that will be ... to restore normal body balance. This treatment can reduce ... pain. In addition, Custom orthotics provides shock absorption, extra ... in relief and greater comfort while walking, running, or ...
(Date:7/23/2014)... In his latest blog post at ... CEO Per Wickstrom explains why entrepreneurs should plan for ... or he has never failed – and quite miserably ... Wickstrom. “Failure is not the opposite of success; it ... it reveals opportunities and shifts perspectives that, ultimately, are ...
(Date:7/23/2014)... A Forever Recovery, an open-ended drug ... a great start and gives them a solid foundation ... new Internet Addiction section of its website at ... that Internet addiction is not just as legitimate a ... it’s trapping more and more victims each year – ...
(Date:7/23/2014)... 2014 In its latest blog post, ... that having family close by during a stay in rehab ... process is successful, is focusing on a topic that is ... addiction-related dialogues: opiate abuse facts. , The Best Drug Rehabilitation ... An overview of opiates, and why they’re considered “the ...
Breaking Medicine News(10 mins):Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:Per Wickstrom’s Latest Blog Post Explains why Entrepreneurs Should Plan for Failure 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2
... several previous studies, Geoffrey R. Howe, Ph.D., of Columbia ... that exposure// to radioactive substances increased cancer risks in ... a study conducted to examine the cancer prevalence showed ... adolescents who are exposed to radioactive iodine. ...
... Medical Association (AMA) has issued a warning that the nation ... due to a lack of clinical expertise. ,Dr ... MPs and senators insisting for a strategy be put in ... number of students. He stated that there would be a ...
... show that the number of sexually transmitted infections is on ... 2005 there was a 3 percent rise in the diagnosis ... increase was reported in syphilis cases at 23 percent, but ... cases of gonorrhea fell by 13 percent. The highest increase ...
... that inhabitants of Phet where hundreds of poultry died last ... a feast on these birds. ,Public health officials ... create awareness of bird flu after hundreds of chicken died ... after a visit to the area that people were disregarding ...
... Kalam, who is on a three-day visit to Orissa, was ... the state board examination despite suffering// from an eye disorder ... the Bhubaneswar Eye Institute (BEI) located on the outskirts of ... and hoped doctors of the institute would find a cure. ...
... and biological timing in the body work much differently ... approach to making drugs for sleep disorders and depression ... an about-face from previous research, said Daniel Forger, assistant ... and his collaborators from the University of Utah's Huntsman ...
Cached Medicine News:Health News:Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine 2Health News:New Sleep Gene Discovery Wakes Up Scientists 2
Townsend is a endocervical stainless-steel curette with round tapered tip....
...
...
...
Medicine Products: